Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancer Medicine|September 8, 2017
Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011Elizabeth Ann L Enninga, Justin C Moser, Amy L Weaver, et al.Molecular Carcinogenesis|March 7, 2012
Regulation of pancreatic cancer growth by superoxideJuan Du, Elke S Nelson, Andrean L Simons, et al.Cancer|June 25, 2026
Updates on intratumoral therapies in melanomaVincent T Ma, Alyssa K Steimle, Janmesh D Patel, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancerAbbie S Ireland, Sarah B Hawgood, Daniel A Xie, et al.Cancer Immunology, Immunotherapy : CII|May 7, 2024
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world dataJustin C Moser, Shailender Bhatia, Asim Amin, et al.Nature|September 17, 2025
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancerAbbie S Ireland, Daniel A Xie, Sarah B Hawgood, et al.BMC Cancer|May 7, 2021
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarkerKristen C Kelley, Kenneth F Grossman, Mary Brittain-Blankenship, et al.Cancer Cell|June 1, 2020
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine FateAbbie S Ireland, Alexi M Micinski, David W Kastner, et al.Investigational New Drugs|March 3, 2023
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumorsAntonio Jimeno, Joaquina Baranda, Wade T Iams, et al.NPJ Precision Oncology|November 14, 2023
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastasesGino K In, Jennifer R Ribeiro, Jun Yin, et al.Pageof 4